Mark E. Diebel
Impact in
- Oncology top 1%
- Cancer Cells and Metastasis
- Chemokine receptors and signaling
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation 3
- Oncology 3
- Cancer Cells and Metastasis 3
- Co-authors
- Daniel Birnbaum (3 shared papers)Christophe Ginestier (3 shared papers)Emmanuelle Charafe‐Jauffret (3 shared papers)Gabriela Dontu (3 shared papers)Max S. Wicha (3 shared papers)Julien Wicinski (2 shared papers)François Bertucci (2 shared papers)Patrice Viens (2 shared papers)
- Journals
- The Journal of Trauma: Injury, Infection, and Critical Care (6 papers)Clinical Cancer Research (1 paper)Journal of Clinical Investigation (1 paper)Medicine (1 paper)Critical Care Medicine (1 paper)
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
Mark E. Diebel
12 papers receiving 2.3k citations
Mark E. Diebel's Hit Papers
Peers
Comparison fields: 5 of 94
- Oncology 1.6k
- Cancer Research 588
- Biotechnology 127
- Molecular Biology 983
- Immunology 289
Countries citing papers authored by Mark E. Diebel
This map shows the geographic impact of Mark E. Diebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Diebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Diebel more than expected).
Fields of papers citing papers by Mark E. Diebel
This network shows the impact of papers produced by Mark E. Diebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Diebel. The network helps show where Mark E. Diebel may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Diebel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature Hit paper breakdown → | 2009 | 975 |
| 2 | CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts Hit paper breakdown → | 2010 | 617 |
| 3 | Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer Hit paper breakdown → | 2009 | 604 |
| 4 | 2017 | 43 | |
| 5 | 2015 | 35 | |
| 6 | 2019 | 26 | |
| 7 | 2011 | 21 | |
| 8 | 2018 | 18 | |
| 9 | 2015 | 15 | |
| 10 | 2020 | 9 | |
| 11 | 2016 | 8 | |
| 12 | 2016 | 7 | |
| 13 | 2013 | 0 |
About Mark E. Diebel
Mark E. Diebel is a scholar working on Critical Care and Intensive Care Medicine, Oncology, Molecular Biology, Gastroenterology and Immunology, having authored 13 papers that have together received 2.4k indexed citations. Recurring topics across this work include Trauma, Hemostasis, Coagulopathy, Resuscitation (3 papers), Cancer Cells and Metastasis (3 papers), Immunotherapy and Immune Responses (1 paper), FOXO transcription factor regulation (1 paper), Gastrointestinal Bleeding Diagnosis and Treatment (1 paper), 3D Printing in Biomedical Research (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (588 citations), Biotechnology (127 citations), Molecular Biology (983 citations) and Immunology (289 citations). Mark E. Diebel has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Daniel Birnbaum, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, Gabriela Dontu, Max S. Wicha, Julien Wicinski, François Bertucci, Patrice Viens, Giorgio Stassi and Flora Iovino. Their work appears in journals such as The Journal of Trauma: Injury, Infection, and Critical Care, Clinical Cancer Research, Journal of Clinical Investigation, Medicine and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.